Insider Cluster (2 insiders) ·Filed May 27, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $131K total
Actionable Insight • Neutral

This cluster is routine and non-informative. The dollar amount is negligible, no C-suite insiders sold, and the price discrepancy between the two trades suggests a possible data anomaly rather than coordinated selling. No action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ONC ▲ +28.87% at T+60d
NEUTRAL call ✓ call won +28.87% · α vs SPY +27.13% · entry $290.58 → $374.47
Entry anchored
May 27, 2026
via day open
T+1d
-0.92%
call -0.92% · α -1.16%
$287.92
settled 4mo ago
T+5d
-3.67%
call -3.67% · α -3.98%
$279.93
settled 4mo ago
T+20d
-3.68%
call -3.68% · α -0.53%
$279.89
settled 3mo ago
T+60d
+28.87%
call +28.87% · α +27.13%
$374.47
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two directors at BeOne Medicines sold a combined $131K in open-market transactions on May 22, 2026. The total value represents ~0.0004% of the $33.6B market cap — a trivial amount. Baker Bros. Advisors LP sold at $23.85/share while Sanders Corazon sold at $309.59/share, suggesting the Baker Bros. trade may involve a different share class or a data error. No C-suite insiders participated, and the dollar amounts are immaterial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$131.0K
Insiders
2

Key Facts

  • Two directors sold a combined $131K in open-market transactions on May 22, 2026
  • Baker Bros. Advisors LP sold 2,743 shares at $23.85/share ($65K)
  • Sanders Corazon sold 212 shares at $309.59/share ($66K)
  • Total sales represent ~0.0004% of ONC's $33.6B market cap
  • No C-suite executives (CEO/CFO) participated in the cluster
  • The large price discrepancy between the two trades ($23.85 vs $309.59) is unusual and may indicate a different share class or data issue

Financial Impact

Total insider sales of $131K — immaterial relative to $33.6B market cap

Risk Factors

  • The $23.85 vs $309.59 price gap between the two trades is unexplained and could indicate a data error or different share class

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONC-1779917200443
19 reports for ONC
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +10.46%Aug 5, 2026
Filters
Rows
Reports for ONC — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Insider Cluster
NEUTRAL ★ 3/10
$346.51 $350.84▲ +1.25%▲ +1.47%$358.07 (+3.34%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$362.68 $346.51▼ −4.46%▼ −3.31%$358.07 (−1.27%)
Aug 26, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$375.80 $361.78▼ −3.73%▼ −3.61%$358.07 (−4.72%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$347.48 $374.47▲ +7.77%▲ +9.14%$358.07 (+3.05%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$356.01 $369.16▲ +3.69%▲ +5.66%$358.07 (+0.58%)
Aug 10, 2026
7w ago
144
BEARISH ★ 6/10
$359.27 $369.15▼ −2.75%▼ −3.15%$358.07 (+0.33%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$329.80 $356.01▲ +7.95%▲ +6.73%$358.07 (+8.57%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$327.53 $359.05▲ +9.62%▲ +9.27%$358.07 (+9.32%)
Jul 24, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$325.90 $322.08▼ −1.17%▼ −1.55%$358.07 (+9.87%)
Jul 17, 2026
11w ago
Insider Cluster
BEARISH ★ 5/10
$312.02 $326.77▼ −4.73%▼ −5.41%$358.07 (−14.76%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (38h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 27, 2026